[HTML][HTML] Multiplexed CRISPR-based microfluidic platform for clinical testing of respiratory viruses and identification of SARS-CoV-2 variants
Abstract The coronavirus disease 2019 (COVID-19) pandemic has demonstrated a clear
need for high-throughput, multiplexed and sensitive assays for detecting severe acute …
need for high-throughput, multiplexed and sensitive assays for detecting severe acute …
Development of a qualitative real-time RT-PCR assay for the detection of SARS-CoV-2: a guide and case study in setting up an emergency-use, laboratory-developed …
BM Shaw, D Slater, EH Byrne… - Journal of Clinical …, 2021 - jcp.bmj.com
Developing and deploying new diagnostic tests are difficult, but the need to do so in
response to a rapidly emerging pandemic such as COVID-19 is crucially important. During a …
response to a rapidly emerging pandemic such as COVID-19 is crucially important. During a …
Author Correction: Multiplexed CRISPR-based microfluidic platform for clinical testing of respiratory viruses and identification of SARS-CoV-2 variants
Author Correction: Multiplexed CRISPR-based microfluidic platform for clinical testing of
respiratory viruses and identification of SARS-CoV-2 variants | Nature Medicine Skip to main …
respiratory viruses and identification of SARS-CoV-2 variants | Nature Medicine Skip to main …
Differences between quantification of genotype 3 hepatitis C virus RNA by Versions 1.0 and 2.0 of the COBAS AmpliPrep/COBAS TaqMan HCV Test
VM Pierce, JS Eversley, TK Tran… - Clinical Chemistry and …, 2017 - degruyter.com
Background: Differences between the designs of hepatitis C virus (HCV) viral load assays
can result in genotype-related variability in RNA quantification. We tested paired aliquots of …
can result in genotype-related variability in RNA quantification. We tested paired aliquots of …
Multiplexed CRISPR-based microfluidic platform for clinical testing of respiratory viruses and SARS-CoV-2 variants (preprint)
NL Welch, M Zhu, C Hau, J Weller, ME Mirhashemi… - 2021 - pesquisa.bvsalud.org
The COVID-19 pandemic has demonstrated a clear need for high-throughput, multiplexed,
and sensitive assays for detecting SARS-CoV-2 and other respiratory viruses as well as their …
and sensitive assays for detecting SARS-CoV-2 and other respiratory viruses as well as their …
[CITATION][C] Multiplexed CRISPR-based microfluidic platform for clinical testing of respiratory viruses and identification of SARS-CoV-2 variants (vol 28, pg 1083, 2022)
NL Welch, M Zhu, C Hua… - NATURE …, 2023 - … HEIDELBERGER PLATZ 3, BERLIN …